Advertisement

Topics

The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research Company Profile

19:17 EDT 14th August 2018 | BioPortfolio


News Articles [2874 Associated News Articles listed on BioPortfolio]

The Michael J Fox Foundation for Parkinson’s Research

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with to Debi Brooks, Co-Founder of The Michael J Fox Foundation for Parkinson’s Research They discuss the foundation's...

The Silverstein Foundation for Parkinson’s with GBA and The Michael J. Fox Foundation for Parkinson’s Research Hold Workshop to Accelerate GBA Therapeutic Development

The Silverstein Foundation for Parkinson’s with GBA and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) held a workshop yesterday to discuss accelerating therape...

The Michael J. Fox Foundation Launches Parkinson’s Clinical Trial Platform

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launched an educational suite dubbed the “Parkinson’s Clinical Trial Companion.”

Alphabet and Michael J. Fox Foundation Team Up to Use Verily Study Watch to Research Parkinson’s Disease

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Verily Life Sciences LLC, an Alphabet company has announced a new collaboration on a two-year sub-study in Parkinson’s Pro...

The Michael J. Fox Foundation for Parkinson's Research Announces Availability of $7 Million in ...

The programs opening today aim to use novel technologies to treat one of Parkinson's most serious symptoms; increase understanding and development of two leading drug Read more...

Charles River Laboratories and Michael J Fox Foundation Extend Collaboration

The Wilmington, Massachusetts-based contract research organization (CRO) Charles River Laboratories International extended its current collaboration with The Michael J. Fox Foundation for Parkinson’...

Charles River Laboratories and Michael J. Fox Foundation Extend Collaboration

The Wilmington, Massachusetts-based contract research organization (CRO) Charles River Laboratories International extended its current collaboration with The Michael J. Fox Foundation for Parkinson’...

Fox Insight’s Observational Clinical Study Offers Hope For Parkinson’s Disease Cures

Clinical Informatics News | The Michael J. Fox Foundation for Parkinson’s Research is using patient reported outcomes to find a cure for Parkinson’s Disease with Fox Insight, a “patient-pow...

Drugs and Medications [1099 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [2517 Associated PubMed Articles listed on BioPortfolio]

Historical and cross-cultural perspectives on Parkinson's disease.

Parkinson's disease (PD) is a common neurodegenerative disorder, affecting up to 10 million people worldwide according to the Parkinson's Disease Foundation. Epidemiological and genetic studies show a...

Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents.

Parkinson's disease (PD) is the second most common neurodegenerative disease, affecting approximately one-percent of the population over the age of sixty. Although many animal models have been develop...

Diabetes mellitus and Parkinson disease.

To investigate whether diabetes mellitus is associated with Parkinson-like pathology in people without Parkinson disease and to evaluate the effect of diabetes mellitus on markers of Parkinson patholo...

The Florence Nightingale Foundation: developing nursing's leaders.

Ursula Ward, Chief Executive, Florence Nightingale Foundation, chiefexec@florence-nightingale-foundation.org.uk , describes the role of the foundation and its plans for the future.

Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease.

The addition of phosphate groups to substrates allows protein kinases to regulate a myriad of biological processes, and contextual analysis of protein-bound phosphate is important for understanding ho...

Clinical Trials [2475 Associated Clinical Trials listed on BioPortfolio]

Molecular Epidemiology of Parkinson's Disease

The aim of this research is to discover genes which modify risk for Parkinson's disease. The study includes 800 patients with Parkinson's disease, and their estimated 1,222 available sibli...

Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)

Prospective observational study of Parkinson's disease with repeat clinical assessment and biobanking of blood samples.

Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease

The aging Veteran population, together with high exposure to Agent Orange or other herbicides during military service, has made diseases such as Parkinson's disease (PD), currently affecti...

Medication Review in Patients on Anti-Parkinson Therapy

To identify patients within the community taking anti-parkinson medications in whom the diagnosis of Parkinson's disease is incorrect and to supervise and clinically monitor the withdrawal...

Parkinson's Families Project

One person in every 500 has Parkinson's and around 127,000 people are living with the condition in the UK. The aim of the study is to identify new genes that predispose or cause Parkinson'...

Companies [2966 Associated Companies listed on BioPortfolio]

The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research

The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed

The Silverstein Foundation is a 501(c)(3) non-profit organization founded in 2017 focused on investing in cutting edge research with the goal of discovering new therapies for the ...

The Michael J. Fox Foundation for Parkinson's Research

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The F...

Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within the coming decade through an aggressively fund...

Brian Grant Foundation

Established in 2010, the Brian Grant Foundation supports efforts to build awareness and education of Parkinson's disease in order to increase earlier diagnosis, educate patients and their families, an...

More Information about "The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research" on BioPortfolio

We have published hundreds of The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research news stories on BioPortfolio along with dozens of The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research Clinical Trials and PubMed Articles about The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research Companies in our database. You can also find out about relevant The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record